Introduction
The transforming growth factor-b (TGF-b) superfamily of extracellular ligands are involved in diverse biological processes during normal development, adult homeostasis and disease. The TGF-b superfamily includes the TGF-bs themselves, activins, and the largest family, the bone morphogenetic proteins (BMPs). BMPs are critical mediators of normal development, regulating fundamental processes such as gastrulation and contributing to the development of nearly every organ system in vertebrate development (Hogan, 1996) . Recent work has demonstrated that BMPs also play a role in the development of cancer of the GI tract (Howe et al., 2001) and breast (Pouliot and Labrie, 2002) . Prostate cancer cells have also been shown to be responsive to BMPs (Brubaker et al., 2004) , suggesting a role in this malignancy in addition to breast and colon. Thus, like the more intensively studied TGF-b signaling pathway, signaling from BMP receptors is also likely to play a role as a tumor suppressor.
BMP ligands exert their effects on target cells largely by the activation of the Smad signaling pathway in a manner common to the entire TGF-b superfamily. Following ligand binding to the type II receptor transmembrane serine-threonine kinase and subsequent transphosphorylation and activation of the appropriate type I receptor, Smad proteins are recruited and phosphorylated on conserved C-terminal serine residues. These so-called R-Smads (for receptor associated Smads) then bind to the common Smad, Smad4, and are translocated to the nucleus where they participate in the regulation of target gene transcription. The R-Smads are classified into those that are activated by TGF-b/ activin signaling, Smad2 and Smad3, and those activated predominantly by BMP signals, Smad1, Smad5 and Smad8. (Massague and Wotton, 2000; Moustakas et al., 2001; von Bubnoff and Cho, 2001) .
Once in the nucleus, Smads bind DNA weakly and act together with many partners in the regulation of target genes. Smad-interacting transcription factors likely account for cell-type-and context-specific-gene regulation characteristic of TGF-b factors (Moustakas et al., 2001) . The mechanism of transcriptional activation induced by Smad proteins is beginning to be understood. Smad proteins appear to regulate transcription through interaction with the paralogous proteins CBP/ p300, which recruit activation complexes and contain histone acetyltransferase activity (Feng et al., 1998; Janknecht et al., 1998) , or possibly through an independent recruitment of P/CAF (Itoh et al., 2000) , another acetyltransferase. The interaction of Smad4 with CBP/p300 is mediated via a region of the middle linker known as the Smad activation domain or SAD (de Caestecker et al., 1997) . Smads may also activate transcription by derepression of transcriptionally inactive sites through competitive association with DNAbound transcriptional repressors (Remacle et al., 1999) . In contrast, much less is known about the mechanism of transcriptional repression by Smad proteins. Although many proteins have been shown to interact with Smads and prevent transcriptional activation through a variety of mechanisms, there has been little work demonstrating the direct repressive activity of Smad proteins on transcriptional targets (Massague and Wotton, 2000) .
Gene expression is regulated both by direct activity of transcriptional complexes on cis elements within target promoters as well as the structure of the chromatin of target genes. Diverse post-translational modifications of histone amino-termini represent an important epigenetic mechanism for the organization of chromatin structure and the regulation of gene activity. The so-called 'histone code' (for reviews Jenuwein and Allis, 2001 ) relies on the fact that histone N-terminal tails are extensively modified by acetylation, phosphorylation, methylation and ubiquitination. The presence of a given modification on the histone tail is thought to specify a 'code' that dictates the regulatory features of a gene. This code is then 'read' by a set of proteins, which translate the code into a particular chromatin state: either active or repressed. Methylation plays an important role in this process (Kouzarides, 2002) . A number of methyltransferases have been discovered and proteins that read the methyl-lysine code have been identified (Rea et al., 2000; Bannister et al., 2001; Lachner et al., 2001) . One class of methyltransferase includes proteins that methylate histone H3 on lysine 9 leading to transcriptional repression or silencing. These proteins, suppressor of variegation 3-9 homolog 1 (Suv39h1) and Suv39h2, display an exquisite site selectivity towards histone H3 lysine 9 (H3K9) methylation. This modification of histone H3 creates a binding site for the chromatin organization modifier (chromo) domain of the heterochromatic HP1 proteins. Suv39h and HP1 functionally interact and modify chromatin leading to transcriptional repression and silencing. These two molecules have been shown to be recruited by the retinoblastoma (Rb) protein to E2F-regulated promoters, thus cooperating in the Rb-mediated repression of the cyclin E promoter (Nielsen et al., 2001; Vandel et al., 2001) . The association of Suv39h proteins and Rb may have important implications in tumor formation. Mutations in Rb found in human cancers do not bind Suv39h1 (Nielsen et al., 2001) , suggesting an important role for this interaction in carcinogenesis. Mice with targeted mutations in both Suv39h1 and Suv39h2 develop spontaneous B-cell lymphomas that resemble human non-Hodgkin lymphomas (Peters et al., 2001) , again underscoring the importance of Suv39h proteins in the regulation of normal cellular function and a role in tumor formation.
In a two-hybrid screen for nuclear factors that regulate Smad transcriptional activity, we found an interaction between Smad5 and Suv39h2. Further studies demonstrated that Suv39h homologues 1 and 2 interact with the BMP-regulated Smad1 and Smad5 in mammalian cells. Taken together, BMP signaling activity and Suv39h histone methylase activity act to repress cooperatively the muscle creatine kinase (MCK) promoter during in vitro differentiation assays. We speculate that interaction of Suv39h and Smad proteins may regulate transcriptional repression on genes specifically inhibited by BMP signaling.
Results

BMP-activated Smad proteins interact with Suv39h proteins
We used a yeast two-hybrid strategy to identify new partners of Smad5. A cDNA sequence containing the linker plus MH2 domains of Smad5 was fused to the Gal4 DNA-binding domain and used as a bait to screen a mouse embryonic E9.5 library constructed from mRNA isolated from embryos and yolk sacs. A total of 4.5 Â 10 6 independent clones were screened, and 356 clones were obtained in the first round. To identify those genes involved in the BMP pathway rather than TGF-b or activin pathways, positive clones obtained in the firstround screen were retested by yeast mating for their ability to interact with other Smads, and only those clones that did not interact with Smad2 or Smad3 were sequenced. Clones containing putative nuclear localization sequences, similarity or identity to known transcription factors, or which encoded proteins known to localize to the nucleus were analysed further. Two independent cDNAs coding for the C-terminal portion of the Suv39h2 protein were shown to interact with Smad1 and Smad5 bait, but not with other Smads in yeast (data not shown).
The two known mammalian isoforms of the Drosophila gene SuVar3-9, Suv39h1 and Suv39h2, share a high degree of sequence identity, with the exception of the N-terminal sequence of Suv39h2, which is not present in Suv39h1. To determine whether Smad5 could interact with both Suv39h proteins, and to confirm the interaction between Suv39h homologs and Smad5 in a mammalian system, we performed transient transfection and co-immunoprecipitation experiments in 293T cells. A plasmid expressing a flag-tagged full-length form of Smad5 was cotransfected with expression plasmids for either myc-tagged Suv39h1 or Suv39h2 proteins. (In this and subsequent experiments, the human form of Suv39h1 and the mouse form of Suv39h2 were used.) In order to induce Smad5 nuclear localization, we also cotransfected an activated form of the type I receptor Alk1 as indicated (In our hands, Alk1 gives equal or better levels of activation of Smad1 or Smad5 compared to constitutively active Alk3 (data not shown).) Cell extracts were immunoprecipitated with anti-myc antibody, and the complexes were observed by immuno-blotting against the flag epitope present on Smad5. As seen in Figure 1a , Smad5 interacted with both Suv39h isoforms, but the Smad5 interaction with Suv39h1 was found to be stronger than with the originally cloned Suv39h2 (Figure 1a , lanes 3-4 vs 5-6). Owing to this apparent higher affinity, we used Suv39h1 in further assays, although we would expect similar results with Suv39h2. As expected, a somewhat greater interaction was observed when constitutively activated Alk1 receptor was cotransfected (Figure 1a , lanes 4 and 6 vs 3 and 5), indicating that Suv39h and Smads interact in the nucleus.
Mating results from the yeast two-hybrid assay suggested that Suv39h2 specifically interacts with BMP Smads but not with TGF-b Smad proteins. In order to determine if the yeast results predicted Suv39h-Smad associations in mammalian cells, we performed coimmunoprecipitation assays using various flag-tagged Smad proteins together with Suv39h1. The 293T cells were transfected with myc-tagged Suv39h1 as well as the indicated flag-tagged R-Smad expression constructs. We used activated Alk5 to induce phosphorylation of Smad2 or Smad3, and activated Alk3 to induce phosphorylation of Smad1 or Smad5. As seen in Figure 1b , Suv39h1 bound strongly to Smad1 and Smad5, with weak and not reproducible binding to Smad2 and Smad3. The differences in binding were not due to differences in expression of the R-Smad constructs, as each was expressed at approximately the same level. Binding of Suv39h1 was strongest with Smad1, suggesting that this interaction has the highest affinity. These data demonstrate that Suv39h proteins interact specifically with Smad1 and Smad5, with much weaker binding to Smad2 and Smad3, which are both regulated by TGF-b and not BMPs.
In order to determine if Smad1 and Suv39h1 interacted in the absence of overexpression, we performed immunoprecipitation and Western blotting assays of endogenous proteins. The K562 human chronic myelogenous leukemia cell line expresses low but detectable levels of Suv39h1 protein (data not shown). We immunoprecipitated Smad1 from K562 cell lysates either treated without or with BMP2 for 3 and 24 h under low serum conditions, and immunoblotted the immunoprecipitates with an antibody specific for human Suv39h1. As a control, we performed identical IP/Blot experiments using lysate from transiently transfected 293T cells as starting material. As can be seen in Figure 1c , BMP treatment resulted in an inducible association of Suv39h1 and Smad1 in this experiment as soon as 3 h after BMP treatment. No association was seen in the absence of treatment with either rabbit IgG-or Suv39h1-specific antibodies. The available antibodies for Suv39h1 are not of high affinity for immunoblot assays, and thus the signal generated is relatively weak. (Compare the K562 lane to the transfected 293 control lane.) Nonetheless, a specific and inducible interaction was observed. To confirm this result, we performed double indirect immunofluorescence on MDA-MB-435 human breast carcinoma cells before and after treatment with BMP. As can be seen in Figure 2a , in the absence of BMP treatment Smad1 is localized diffusely in both the cytoplasm and the nucleus, while following BMP stimulation there is a significant increase in Smad1 nuclear staining. Suv39h1 staining is primarily nuclear both in the absence and presence of BMP. In the absence of BMP, there is little if any association of Suv39h1 and Smad1; however, after 1 h of BMP treatment, a specific and inducible colocalization is observed. The amount of colocalization is quantitated in Figure 2b , where the number of overlapping pixels before and after treatment is presented. There is little, if any, overlap before BMP treatment, while after the addition of BMP there is a large and statistically significant increase in the number of sites occupied by Suv39h1, which are also occupied by Smad1. Taken together, these data support the findings of the overexpression studies and demonstrate that association of Smad1 and Suv39h1 is not an artifact of the overexpression system used.
Smad1 interacts with an internal region of Suv39h1
In order to investigate the regions of Suv39h1 involved in binding Smads, we used different constructs of myctagged Suv39h1 in co-immunoprecipitation assays (Figure 3 ). Flag-tagged Smad1 was tested for association with various Suv39h constructs by immunoprecipitation of myc-tagged Suv39h1 constructs followed by immunoblotting of the Flag epitope tag. We used mutants lacking the SET domain (DSET), containing only the N-terminal chromo domain (Nchromo), one construct lacking the N-terminus (DN89) and an internal deletion that abrogates SET domain methyltransferase activity (DNHSC) (Figure 3b ). As seen in Figure 3a , only the Nchromo construct, which contains only amino acids (aa) 3-118, was not able to bind to Smad1. This result matches that of the previously obtained fragments of Suv39h2 isolated in the yeast two-hybrid screen (data not shown). Curiously, internal deletions within the SET domain that eliminate methyltransferase activity (deletions of aa 323-329, DNHSC) significantly increased the amount of Smad1 protein associated with Suv39h1 in the immunoprecipitation. Taken together, these data indicate that Smad1 (and presumably Smad5) bind to an internal region of Suv39h1 molecule (aa 118-249) . This region of the molecule has not yet been characterized well for its functional characteristics.
Smads and Suv39h1 cooperate to regulate transcription of MCK
Suv39h1 is a transcriptional repressor as a GAL4 fusion (Firestein et al., 2000) and localizes to transcriptionally silent heterochromatic sites (Aagaard et al., 1999) . Other studies corroborate Suv function as a repressor in an artificial gene-specific targeting system in vivo (Snowden et al., 2002) . HP1, also a transcriptional repressor, colocalizes with Suv39h1 at heterochromatic sites and is able to bind to histone H3 when the latter is methylated at lysine 9 by Suv39h proteins Lachner et al., 2001) . Evidence that the Suv39h1/HP1 complex is involved in transcriptional repression at euchromatic loci comes from the finding that the Rb protein recruits Suv39h1/HP1 to cell-cycle-regulating genes such as cyclin E (Nielsen et al., 2001; Vandel et al., 2001) . In Rb-null cells, the cyclin E promoter is undermethylated at lysine 9 and HP1 is not associated with the cyclin E upstream regulatory elements. These results emphasize that methylation and subsequent HP1 binding do not occur indiscriminately, but rather are targeted events. To investigate whether Suv39h1 could repress transcription in a Smad1-dependent manner, we assayed the transactivation activity of both proteins on BMP-regulated reporters. To do this, we first assayed a heterologous system using the DNA-binding domain of GAL4 fused to Suv39h1 and cotransfection with Smad1. We did not obtain a significant repression of luciferase activity of a Gal4 reporter in transactivation assays (data not shown). Similarly, when we used a Smad1-Gal4 fusion, we did not see a significant repression of transcription when exogenous Suv39h1 was added (data not shown).
Since there was no repression in a heterologous assay, we reasoned that only in a situation where BMP signaling would normally repress transcription would we see an effect of Smad1 and Suv39h1 association. We therefore decided to use a promoter normally repressed by Smad1 to assay the role of Suv39h1 as a corepressor. Published data demonstrated that expression of the MCK gene is downregulated when myogenic conversion is inhibited by BMP treatment in C2C12 myoblasts (Akiyama et al., 1997) . It had previously been shown that TGF-b treatment can also repress MCK induction by MyoD, in part by Smad3 sequestration of MyoD away from cis-regulatory elements (Liu et al., 2001) . We first determined that MCK promoter activity could be inhibited by BMP signaling in cells induced to undergo Smads and Suv39h interact in corepression P Frontelo et al myogenic conversion. To do this, we cotransfected an MCK-luc reporter containing just the proximal E-boxactivating elements along with constitutively activated BMP receptor type I, Alk3, in C2C12 myoblasts, which had been induced to form myotubes by treatment with 2% horse serum. As predicted, a constitutively active Alk3 construct inhibited MCK activity (Figure 4a) . Cotransfection of increasing amounts of Suv39h1 caused a dose-dependent decrease in MCK promoter activity, both alone or when coexpressed with Alk3. To confirm these data, we induced myogenic conversion in a different system. C3H10T1/2 mouse fibroblasts can be induced to express a muscle phenotype by transfecting them with a MyoD, followed by serum withdrawal. The results obtained in these cells transfected with a fulllength MCK-luc reporter are shown in Figure 4b . As in the C2C12 cells, the partial repression obtained by the activation of BMP signaling was increased by the addition of the Suv39h1 construct. We also tested the role of exogenous Smad1 in this assay. As can be seen in Figure 4b , addition of exogenous Smad1 alone had no effect on promoter activity, while in the presence of activated Alk3, it further repressed MCK activity. Cotransfection of Smad1, Suv39h1 and Alk3 nearly completely suppressed MCK promoter activity in this system. Treatment with BMP resembled the effects of Alk3 transfection. As shown is Figure 4c , the decrease in MCK promoter activation was dependent on the dose of BMP2 used, and expression of Suv39h1 cooperated in repressing the promoter.
In order to determine if Suv39h proteins indiscriminately suppress BMP-dependent promoter activity, we tested the role of Suv39h2 in suppressing a promoter activated by BMP signaling. The Tlx-2 promoter is induced by signaling through Smad1 and Smad5, but not Smad2 or Smad3 (Macias-Silva et al., 1998) . We cotransfected the Tlx-2-luc reporter with the constitutively activated type I receptor Alk1, which activates Smad1 and Smad5 or Alk5, which activates Smad2 and Smad3, into P19 cells. In contrast with the above results, no changes in luciferase activity were observed after cotransfection with Suv39h2 (Figure 4d ). The BMPresponsive BRE promoter is also positively activated by BMP R-Smad signaling. Similar to the above results, activation of the BRE reporter by BMP2 was not inhibited by the addition of exogenous Suv39h1 at doses that had a clear effect on the MCK promoter (Figure 4e ). These results indicate that the activity of Suv39h isoforms as corepressors is targeted specifically to genes that are negatively regulated by Smad proteins, and that it does not globally repress transcription of exogenously introduced promoters.
In the above experiments, there is some repression of promoter activity in the absence of BMP signaling either by the addition of ligand or use of activated receptors. This could be due to autocrine stimulation or possibly an artifact of overexpression, since Suv39h levels are normally quite low (Chakraborty et al., 2003) . To further investigate the mechanism of corepression, we expressed mutant constructs of Suv39h1 in the same reporter assays described above. We used the 10T1/2 cell system in order to test the role of the SET domain in mediating transcriptional repression. The SET domain is the methyltransferase domain, and deletion of the domain blocks the ability to methylate histone H3. Cotransfection of an Suv39h1 construct lacking the SET domain (DSET) drastically reduced the cooperative effects of Alk3 and Suv39h1 on MCK inhibition in cells transfected with Alk3 as shown in Figure 5a . The residual amount of transcriptional repression may be due to the repression domain located in the N-terminus (Vaute et al., 2002) . These data demonstrate that the methylase activity of Suv39h1 is necessary for the repression of MCK promoter activity by Suv39h proteins in cooperation with Smad signaling. To test whether interrupting the BMP pathway would interfere with Suv39h1-induced repression, we coexpressed Melcher et al. (2000) . The solid area represents the N-terminal tail, the white box is the chromo domain, the speckled box is the linker and the gray box is the SET domain. The asterisk indicates the small deletion of the NHSC construct. Relative Smad1 binding is indicated Smad1-3S4A, a construct with a mutation that abolishes Smad1 phosphorylation, together with Suv39h1 in the 10T1/2 differentiation system. As shown in Figure 5b increasing amounts of Smad1-3S4A acted as a dominant inhibitory mutant of Smad1, reversing endogenous inhibition of the promoter induced by BMP signaling. Most importantly, when Smad1-3S4A mutant was coexpressed with Suv39h1, it completely relieved Suv39h1-induced inhibition. Partial reversion of Suv39h1 inhibition was also observed with a Smad5-3S4A dominant inhibitory mutant together with Suv39h1 (data not shown). Thus, inhibition of MCK promoter activity by Smad proteins is partially dependent on Suv39h methylase activity, and Suv39h-mediated repression is similarly dependent on Smad activity. Taken together, these data strongly suggest that Smad1 and/or Smad5 along with Suv39h proteins repress MCK promoter activity through a cooperative mechanism.
Discussion
BMPs control cell growth, differentiation and survival, and have been shown to be particularly important during embryonic development (Whitman, 1998; von Bubnoff and Cho, 2001 ) and in human disease including vascular disorders (Caestecker and Meyrick, 2001 ) and cancer (Howe et al., 2001) . BMP family ligands signal their effects through Smad proteins, which are activated by receptor phosphorylation, translocate into the nucleus and act as transcriptional cofactors. In the cases where Smad proteins suppress transcription, most examples published to date indicate a competitive interaction with positive acting transcription factors or cofactors. Two examples of alternative mechanisms have been described. The homeodomain protein TGinteracting factor has been shown to bind to Smad2 and recruit histone deacetylase (HDAC) activity via CtBP (Melhuish and Wotton, 2000) . In a slightly different scenario, Smad3 and Smad4 can recruit the oncogene products Ski and SnoN, which serve to suppress transcriptional activity in part through the association of NcoR/SMRT/mSin3 and HDAC activity (Luo et al., 1999) . Interestingly, Smad3 can also recruit HDAC activity independent of association with Ski or SnoN, suggesting yet another mechanism for transcriptional repression (Liberati et al., 2001) . The above mechanisms seem to operate on promoters that can be either activated or repressed by TGF-b, depending on the relative levels of expression of the various components. Thus, recruitment of HDAC activity and transcriptional repression in these cases appears to depend on the relative levels of expression of the various components and not on the nature of the promoter itself.
Here we show that Smad1 and Smad5, which are primarily regulated by BMP signaling, can associate with histone methyltransferases of the Suv39h family, and that this interaction contributes to the repression of promoters that are specifically repressed by BMP signaling. The existence of the Smad-Suv39h1 repressor complex is a novel link between transcriptional regulation by the TGF-b family and chromatin modification. We propose that BMP R-Smads are directly targeting Suv39h methyltransferase activity to genes that are repressed by BMP signaling activity. Our interaction data demonstrate that Smad1 and Smad5 specifically can interact with Suv39h1 and Suv39h2, the two identified mammalian homologues of the product of the Drosophila gene product SuVar-3-9, which has been shown to be important in transcriptional silencing of heterochromatic and euchromatic elements. In addition, we have shown that this association results in enhanced transcriptional repression of a promoter known to be repressed by BMP signaling. Subsequent methylation of histone H3 on lysine 9 would then initiate recruitment of HP-1 proteins and transcriptional silencing. This would provide a mechanism for BMP-targeted transcriptional silencing during fundamental processes of organismal development and growth. Although we have demonstrated the functional consequences of Smad-Suv interaction in transient transfection experiments, these assays are likely to be representative of conditions present in the intact genome. DNA and histones are known to form complexes in vitro (Davey et al., 2003) , and transient transfection of DNA results in the generation of minichromosomes that contain a normal complement of core histones, including histone H3 (Reeves et al., 1985) . Studies of transient vs stable transfections and effects of chromatin remodeling have been shown to produce equivalent results (Keeton et al., 2002) , and factors such as trichostatin A, which alter HDAC activity are known to work in transient assays (Cong and Bacchetti, 2000) .
Although Suv39h proteins are primarily known to regulate transcriptionally silent heterochromatin, targeting of Suv39h1 to transcriptionally active euchromatin has been described. Rb protein and Suv39h1 cooperate in the repression of the cyclin E promoter through a mechanism that involves the recruitment of Suv39h1 by Rb (Nielsen et al., 2001; Vandel et al., 2001) , and pRB2/ p130/Suv multimolecular complexes have been shown to regulate estrogen receptor-a transcription (Macaluso et al., 2003) . Suv39h proteins have also been shown to associate with the thyroid hormone receptor in its repressive, unliganded state (Li et al., 2002) . Recently, Suv39H1 has been shown to interact with and methylate the transcription factor AML1 (Chakraborty et al., 2003) . Our data demonstrate that Suv39h1 acts as a cofactor in the repression of the MCK promoter induced by BMP signaling, either in C2C12 myoblasts undergoing myogenic differentiation by serum withdrawal or in differentiating MyoD-overexpressing C3H10T1/2 fibroblasts. This provides the first example of Smad targeting of a histone methyltransferase to a specific genetic element, and suggests a model for transcriptional silencing by the Smad proteins.
Transcriptional repression by Suv39h proteins may occur by both methyltransferase-dependent and -independent mechanisms (Vaute et al., 2002) . In our hands, the cooperation of Suv39h1 with Smad1 in repressing MCK promoter activity was largely dependent on histone methyltransferase activity. Mutants of Suv39h lacking the SET domain showed a decrease in promoter repression compared to wild type, either alone or in the presence of BMP signaling activity. Interestingly, mutants of Suv39h1 lacking histone methyltransferase activity showed a partial relief of the inhibition caused by BMP treatment. This suggests that these mutants can act as dominant inhibitory proteins in this pathway. Similarly, blockade of Smad signaling caused a reversal of repression caused by the overexpression of Suv39h1. When expressed alone, the Smad1(3S4A) construct, which cannot be phosphorylated and hence activated by the type I receptor, blocked the endogenous activation of BMP pathway, which resulted in an increase in MCK promoter activity. When coexpressed with Suv39h1, Smad1(3S4A) completely reversed inhibition caused by the histone methyltransferase. A similar pattern was observed using a Smad5 mutant (data not shown). These data demonstrate that active Smad signaling targets Suv39h methyltransferase activity to the MCK promoter, and that this activity is necessary for repression induced by the Smad-Suv39h complex.
Experiments designed to map the Smad-binding domain of Suv39h1 showed that an internal domain of the molecule that excludes the chromo or SET domains interacts with Smad1. Whether this domain can interact with other transcription factors, targeting its enzymatic activity to other repressed genes, is yet to be determined. In addition, neither the yeast nor the mammalian transfection data conclusively demonstrate that the interaction is direct and not mediated by other proteins. The region that we have mapped as responsible for Smad binding has not had other functions ascribed to it, and it may serve as a general site for binding of factors that target the protein to specific elements. We consistently observed a stronger association between Smad1 and Suv39h1 when the methyltransferase activity of Suv39h1 was inactivated by mutation of aa 323-329 (DNHSC). One possible explanation for this is that after Smad1 delivers Suv39h1 to the repressor complex, it is then released when the enzyme is inactive. Further experiments isolating the complex will help to define the exact mechanism of repression.
Cell differentiation is achieved by the expression of a set of cell-type-specific proteins as well as the repression of others that would commit the cell to a different phenotype. The interaction of Smad1 and Suv39h1 induced by BMP signaling may serve not only to block transiently induction of expression of myogenic proteins but may also induce a transcriptionally silenced or repressed state on myogenic promoters by inducing methylation at lysine 9 on histone H3. In this model, C2C12 myoblast cells are in a multipotent state, with muscle-specific genes in a repressed state. Upon myogenic stimulation, these promoters will be activated in part by histone acetylation, and the cells will undergo differentiation into myotubes. In contrast, a BMP stimulus will silence the myogenic promoters by methylation of histone H3K9 and will induce the expression of osteoblast-specific genes at the same time, committing the cells to the osteogenic phenotype. We speculate that the recruitment of the Suv39h-HP1 repressor complex by Smad proteins may be a generalized mechanism of generating epigenetic transcriptional silencing that is important for induction and maintenance of a specific cell phenotype.
Materials and methods
Yeast two-hybrid interactions
A cDNA encoding the linker and the MH2 fragment of Smad5 was fused in frame to the GAL4 DNA-binding domain of pGBKT7 (Clontech) to construct the bait plasmid. An E9.5 mouse library was prepared in lambda vectors using Stratagene HybriZAP s 2.1 two-hybrid vector system and mRNA obtained from embryos and yolk sacs. Prey cDNAs were obtained by converting the lambda vectors using in vivo mass excision. Bait and library constructs were subjected to yeast two-hybrid assays by cotransformation in AH109 strain and selected under a high-stringency protocol -ADE2/HIS3/lacZ/ MEL1, 15mM 3-AT -as described by the manufacturer (Clontech). To validate the interaction, we performed mating assays using selected positive clones expressed in AH109 yeast strain and the Smad5 bait in Y189 strain. Full-length forms of Smad1 and Smad5, and the MH2 domain of Smad5 were cloned in pGKBKT7 vector, whereas full-length Smad3 and Smad4 cDNAs cloned in pGBT9 were obtained from Dr Rik Derynck, in order to perform in parallel mating experiments. Positive clones were sequenced using Big Dye termination (ABI).
Cell culture, transfections and induction of myogenic differentiation
The 293T cells (ATCC) were grown in DMEM with 10% FBS and transfected by calcium phosphate co-precipitation. C3H10T1/2 mouse fibroblasts and C2C12 myoblasts (ATCC) were cultured as described (Fujii et al., 1999) . Cells were grown in subconfluent conditions before the initiation of myogenesis, which occurred when cells were transferred to differentiation medium (DM) containing 2% horse serum. DNA constructs were transfected into 10T1/2 or C2C12 cells by Lipofectamine 2000 reagent (Invitrogen). 10T1/2 cells transfected with a MyoD expression construct were grown in DM for 2 days following transfection. Differentiation of C2C12 myoblast cells was initiated by shifting subconfluent monolayer cells grown in GM to DM, and cells were used after 2 days.
Immunofluorescence MDA-MB-435 cells were grown on gelatin-coated coverslips in DMEM with 0.2% FBS overnight. Cells were left untreated or treated with 50 ng/ml BMP2 for 1 h. Suv39h1 was detected with a mouse monoclonal Ab for Suv39h1 at a 1 : 100 dilution (Upstate Biotechnology) and Smad1 was detected with a rabbit polyclonal Ab for Smad1 at a 1 : 100 dilution (Upstate Biotechnology) using published protocols (de Caestecker et al., 1998) . AlexaFluor 488 (goat anti-mouse) and AlexaFluor 647 (goat anti-rabbit) (Molecular Probes) were used as secondary Abs. DAPI was detected using Vectashield Mounting Medium with DAPI (Vector Laboratories, Inc.) . Control experiments demonstrated no crossreactivity between anti-mouse secondary and rabbit primary antibodies and vice versa. Nor was there detectable staining by secondary antibodies only (data not shown). Images were obtained on an Olympus Fluoview 500 confocal microscope at Â 63 magnification. Image analysis was performed by counting Suv39h1 staining pixels and Smad1 staining pixels of 36 different cells for each treatment and determining overlap using Metamorph software. Differences between overlap in images of untreated and treated cells were analysed statistically using Student's t-test. Representative results from two independent experiments are shown.
Immunoprecipitation and protein analysis
The 293T cells were harvested 2 days after transfection, washed once with PBS and lysed in IP buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 1% NP-40, 1 mM EDTA, 10% glycerol, 10 mM glycerophosphate, 1 mM NaF, 0.1 mM NaVO 3 , 1 mM DTT and protease inhibitors), sonicated twice for 10 s and insoluble material was removed by a 20 min centrifugation at 15 000 r.p.m. at 41C (Aagaard et al., 1999) . Supernatant was taken for immunoprecipitation analysis. In some experiments, a previous nuclear fractioning using hypotonic buffer was performed before IP buffer was added. 9E10 anti-myc Ab (Santa Cruz) was used to analyse complexes formed with myctagged Suv39h proteins overexpressed in 293T cells. After overnight incubation proteins were precipitated using protein A/G-agarose beads (Pierce) for 2 h at 41C. The beads were pelleted, washed five times in immunoprecipitation wash buffer (150 mM NaCl, 20 mM HEPES (pH 7.9), 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride) and resuspended in 2 Â SDS sample buffer (4% SDS, 10% 2-mercaptoethanol, 100 mM Tris (pH 6.8), 20% glycerol). Eluted proteins were boiled, separated by SDS-PAGE, transferred to nitrocellulose (Bio-Rad) and subjected to Western blot analysis using Abs specific for flag, myc or the HA epitope (Santa Cruz). Immune complexes were detected using a secondary horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit antibody (KPL) and visualized by chemiluminescence (Amersham). For evaluation of endogenous proteins in K562 cells, experiments were performed in an identical manner using antibodies to Smad1 and Suv39h1 (Upstate Biotechnology, Inc.).
Transcriptional assays
To assay the activity of the MCK promoter, we used the reporter plasmid MCK-luc, which contains the proximal 4800 bp promoter/enhancer region of the MCK gene driving luciferase expression, or E-box-luc, which contain four tandem repeats of the high-affinity right E-box site from the MCK enhancer linked to luciferase. Transfections were internally controlled by cotransfection of CMV-Renilla luciferase. After the induction of myogenic differentiation for 2 days, luciferase assays were performed using commercially prepared reagents (Promega). Promoter luciferase values were normalized using Renilla values. Data points represent the average normalized activity in lysates prepared from two identically transfected samples. Each experiment was repeated at least once. Error bars are standard error of the mean.
